Human Bone Marrow CD33+ Myeloid Cells

Description

Human Bone Marrow CD33+ Myeloid Cells are primarily derived from myeloid progenitor cells in the bone marrow and are associated with the development of myelogenous cells within the hematopoietic hierarchy. Morphologically, these cells typically possess round or irregular cell bodies with a relatively high nuclear-to-cytoplasmic ratio. CD33+ myeloid cells express the myeloid differentiation antigen CD33, a transmembrane glycoprotein involved in the growth, differentiation, and immune regulation of myeloid lineage cells. These cells may also express other myeloid-related markers, such as CD11b and HLA-DR. Functionally, CD33+ myeloid cells play an important role in the hematopoietic system, participating in the generation and differentiation of myeloid cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.